VitaStem is an innovative token that represents the first AI-enabled longevity project initiated by Aubrai, a decentralized scientific agent of VitaDAO. This token stems from extensive research into the aging of human hematopoietic stem cells, leveraging both public and proprietary datasets. The scientific team has meticulously analyzed over 850,000 transcriptomes from donors aged 23 to 91, uncovering more than 100 rejuvenation target genes and identifying key factors contributing to age-related decline. The research recognizes that aging in hematopoietic stem cells is a complex issue involving multiple systems rather than a singular defect. Consequently, the project has developed a comprehensive five-phase rejuvenation protocol that addresses transcriptional stress, metabolic dysfunction, and epigenetic drift simultaneously. This multi-modal approach aims to enhance the understanding and treatment of stem cell aging. Aubrai's methodology integrates insights from thousands of peer-reviewed studies, which helps in the selection of target genes for further exploration. Additionally, the project has refined experimental protocols to facilitate in vitro studies and forthcoming pre-clinical testing. This pioneering effort marks a significant collaboration between human researchers and AI agents, emphasizing the role of technology in advancing scientific discovery. VitaStem is positioned at the forefront of longevity research, offering a unique opportunity to explore the potential of rejuvenation therapies. The token serves as a bridge connecting groundbreaking scientific research with the cryptocurrency ecosystem, making it a valuable asset for those interested in the future of health and longevity.